GlaxoSmithKline (GSK) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
GlaxoSmithKline (GSK) has announced that its issued share capital as of October 31, 2024, consists of over 4.3 billion ordinary shares, with a total of approximately 4.1 billion voting rights available. This information is crucial for shareholders calculating their interest in the company as per regulatory guidelines.
For further insights into GSK stock, check out TipRanks’ Stock Analysis page.
